http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2398579-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00 |
| filingDate | 2009-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc5c516f223bc0ebb06f5d959f95628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5473f5dcfc7748555aa84f412e4b505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120321d1a6e1aaac72d816e5c5cf8ef7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e |
| publicationDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2398579-C1 |
| titleOfInvention | Method of normalising functional responsiveness of cardiovascular system in arterial hypertension, impaired glucose tolerance and abdominal obesity and stage i impaired cardiac function |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to haematology, cardiology, endocrinology and can be used for normalising the functional responsiveness of cardiovascular system (CVS) in arterial hypertension, impaired glucose tolerance, abdominal obesity and stage I impaired cardiac function. That is ensured by estimating the state of functional responsiveness of the CVS in psychoemotional load. And systolic, diastolic, average dynamic pressure and heart rate (HR) are recorded. These data are used to evaluate a functional responsiveness index (FRI) before and after load by formula: FRI=(BPav.dyn. รน HR)/100 (standard units). The FRI exceeding 20 standard units required a therapy to be prescribed. The therapy combines the individually prescribed hypocaloric diet, rationally graduated static and dynamic physical activity, and administration of lisinopril 10 mg once in the morning and metformin 500 mg twice a day. The length of treatment is at least 3 weeks. ^ EFFECT: method allows for well-timed diagnosis of the impaired functional responsiveness of CVS; and the combination of presented modalities ensures the effective correction, prevention of complications of arterial hypertension and impaired glucose tolerance, abdominal obesity and stage I impaired cardiac function. ^ 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2607186-C1 |
| priorityDate | 2009-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.